Iinuma, K.; Kameyama, K.; Kawada, K.; Fujimoto, S.; Takagi, K.; Nagai, S.; Ito, H.; Ishida, T.; Kawase, M.; Kawase, K.;
et al. Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Curr. Oncol. 2021, 28, 1402-1411.
https://doi.org/10.3390/curroncol28020133
AMA Style
Iinuma K, Kameyama K, Kawada K, Fujimoto S, Takagi K, Nagai S, Ito H, Ishida T, Kawase M, Kawase K,
et al. Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Current Oncology. 2021; 28(2):1402-1411.
https://doi.org/10.3390/curroncol28020133
Chicago/Turabian Style
Iinuma, Koji, Koji Kameyama, Kei Kawada, Shota Fujimoto, Kimiaki Takagi, Shingo Nagai, Hiroki Ito, Takashi Ishida, Makoto Kawase, Kota Kawase,
and et al. 2021. "Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study" Current Oncology 28, no. 2: 1402-1411.
https://doi.org/10.3390/curroncol28020133
APA Style
Iinuma, K., Kameyama, K., Kawada, K., Fujimoto, S., Takagi, K., Nagai, S., Ito, H., Ishida, T., Kawase, M., Kawase, K., Nakai, C., Kato, D., Takai, M., Nakane, K., & Koie, T.
(2021). Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Current Oncology, 28(2), 1402-1411.
https://doi.org/10.3390/curroncol28020133